Methods and systems for establishing retrograde carotid arterial blood flow
Interventional procedures on the carotid arteries are performed through a transcervical access while retrograde blood flow is established from the internal carotid artery to a venous or external location. A system for use in accessing and treating a carotid artery includes an arterial access device, a shunt fluidly connected to the arterial access device, and a flow control assembly coupled to the shunt and adapted to regulate blood flow through the shunt between at least a first blood flow state and at least a second blood flow state. The flow control assembly includes one or more components that interact with the blood flow through the shunt.
1. A carotid artery lesion treatment system, comprising:
an arterial access sheath configured for placement into a common carotid artery at an insertion site in a patient's neck;
a blood-flow block configured to be inserted via the arterial access sheath into the common carotid artery and to block blood flow in at least a portion of the common carotid artery to establish retrograde blood flow through the common carotid artery such that blood flows into a lumen of the arterial access sheath;
an extracorporeal shunt configured to allow the retrograde blood flow to pass from the common carotid artery to a femoral vein of the patient;
wherein the access sheath is configured to allow deploying a stent to the lesion, and wherein the arterial access sheath includes a proximal extension and a proximal hemostasis device at a proximal end of the proximal extension, and wherein the proximal extension has a length sufficient to space the hemostasis device a distance away from a insertion site such that a clinician can introduce a treatment device into the proximal extension and sheath while lessening radiation exposure to the clinician when fluoroscopy is being performed.
2. The carotid artery lesion treatment system of claim 1 , wherein extracorporeal shunt has a length and an inner diameter, and wherein a ratio of the length to the inner diameter of the shunt is in the range of 84 to 147.
3. The carotid artery lesion treatment system of claim 1 , wherein the access sheath has a length sufficient to space a hemostasis device a distance away from the insertion site such that a clinician can introduce a treatment device into the sheath while lessening radiation exposure to the clinician when fluoroscopy is being performed.
4. The carotid artery lesion treatment system of claim 1 , further comprising a filter that is configured to be deployed in the arterial blood system at a location distal of the lesion.
5. The carotid artery lesion treatment system of claim 1 , wherein the arterial access sheath comprises a working length of 5 cm to 15 cm.
6. The carotid artery lesion treatment system of claim 1 , wherein the extracorporeal shunt includes a stopcock.
7. The carotid artery lesion treatment system of claim 6 , wherein the extracorporeal shunt includes a filter.
8. The carotid artery lesion treatment system of claim 1 , wherein the shunt has a length of 40 cm to 70 cm.
9. The carotid artery lesion treatment system of claim 1 , wherein the shunt has an internal diameter of 4.76 mm.
10. A carotid artery lesion treatment system, comprising:
an arterial access sheath configured for placement into a common carotid artery at an insertion site in a patient's neck;
a blood-flow block configured to be inserted via the arterial access sheath into the common carotid artery and to block blood flow in at least a portion of the common carotid artery to establish retrograde blood flow through the common carotid artery such that blood flows into a lumen of the arterial access sheath;
an extracorporeal shunt configured to allow the retrograde blood flow to pass from the common carotid artery to a femoral vein of the patient, wherein the extracorporeal shunt includes a stopcock and a filter;
wherein the access sheath is configured to allow deploying a stent to the lesion, and wherein the arterial access sheath includes a proximal extension and a proximal hemostasis device at a proximal end of the proximal extension, and wherein the proximal extension has a length sufficient to space the hemostasis device a distance away from the insertion site such that a clinician can introduce a treatment device into the proximal extension and sheath while lessening radiation exposure to the clinician when fluoroscopy is being performed.
11. The carotid artery lesion treatment system of claim 10 , wherein extracorporeal shunt has a length and an inner diameter, and wherein a ratio of the length to the inner diameter of the shunt is in the range of 84 to 147.
12. The carotid artery lesion treatment system of claim 10 , wherein the access sheath has a length sufficient to space a hemostasis device a distance away from the insertion site such that a clinician can introduce a treatment device into the sheath while lessening radiation exposure to the clinician when fluoroscopy is being performed.
13. The carotid artery lesion treatment system of claim 10 , further comprising deploying a filter in the arterial blood system at a location distal of the lesion.
14. The carotid artery lesion treatment system of claim 10 , wherein the arterial access sheath comprises a working length of 5 cm to 15 cm.
15. The carotid artery lesion treatment system of claim 10 , wherein the shunt has a length of 40 cm to 70 cm.
16. The carotid artery lesion treatment system of claim 10 , wherein the shunt has an internal diameter of 4.76 mm.